Pharma Pricing, Reimbursement & Market Access 2024

8th Annual Pharma Pricing, Reimbursement & Market Access 2024

19th – 20th September 2024, Live Casino Hotel, Philadelphia, USA

This conference will provide an overview of global pharma pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 8th Annual Pharma Pricing, Reimbursement & Market Access 2024. I wish and pray that all our efforts will be beneficial to our industry and to our country at large.

Please contact Kavitha at E-mail - or call +44 20 3509 3779

DELEGATE REGISTRATION:

Super Early Bird (Valid Till 19th July)

1 Delegate @ $999

Group Discount @ $1998 (3 Delegates for the price of 2)

Early Bird (Valid from 20th July - 2nd Aug )

1 Delegate @ $1299

Group Discount @ $2598 (3 Delegates for the price of 2)

STANDARD PRICE ( Valid from 03rd Aug)

1 Delegate @ $1599

Group Discount @ $3198 (3 Delegates for the price of 2)

SPONSORS:

Gold Sponsor - Red Nucleus

Consulting partner - ElevateMIAccess

We have sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. Here you can have a dedicated networking time, meet the leading international vendors and expand your knowledge of the latest business models. Please email to [email protected] for more details.

KEY SPEAKERS:

• DAVID BOWER, Senior Director - U.S. Value & Access – Dermatology, Sanofi Genzyme
• RODNEY EMERSON, Vice President, Pricing & Contracts, Sandoz
• NANCY RUSCIO-BELL, VP, Head of US Patient Value & Access, Takeda
• JASON LOTT, VP Global Integrated Evidence Generation, Bayer
• DINA INVERSO, VP US Market Access, Policy & Reimbursement Lead, GE Healthcare
• BOXIONG TANG, AVP, Head of HEOR & Medical Value Access, Agenus
• TOM CROCE, VP, Global Patient Advocacy, Jazz Pharmaceuticals
• GARY ELLEXSON, Corporate Accounts, Supernus Pharmaceuticals
• KATYE GEMMA, Director & Senior Counsel II - Market Access, Boehringer Ingelheim
• ROBERT ROUSE, Head of Market Access, CSL Behring
• JASON M. NOTO, Senior VP, US Market Access, AVEO Oncology
• ALAN POLNARIEV, National Clinical Account Director - VA & DoD, AstraZeneca
• YONG CHEN, Sr. Director, Real World Evidence, Oncology, Pfizer
• ANKA G. EHRHARDT, Director, Cell-Based Assays / Analytical Research & Development, Merck
• JOAQUIN F. MOULD, Global HEOR & Value Strategy Director, CSL Seqirus
• PETER BARSCHDORFF, Vice President, Deallus
• YAOZHU (JULIETTE) CHEN, Evidence Strategist, Patient-Centric Developer, Value Solution Leader, AstraZeneca
• STEPHEN FRAMIL, Corporate Global Head of Accessibility, Merck
• DINAKARAN BALASUBRAMANIAN, Head, Commercial Strategy & Insights, Biologics, Dr. Reddy’s Laboratories
• MARTIN ROST, Former Senior Director, Market Access (Global), Pfizer
• USMAN IQBAL, Chief Medical Officer, Julz Pharma
• MARGARET REHAYEM, Former VP, National Alliance of Healthcare Purchaser Coalitions
• HEATHER LEIGH FLANNERY, CEO & Co-Founder, AI MINDSystems Foundation
• AYESHA AZAM, Associate Principal, Avalere Health
• SUSAN THORNTON, CEO, Cutaneous Lymphoma Foundation
• REED STEPHENS, Partner, Winston & Strawn
• JOLIE APICELLA, Partner, Wiggin and Dana
• CHRISTOPHER H. SCHOTT, Partner, LATHAM & WATKINS

Plus more joining soon

KEY THEMES:

• Emerging trends & vision for future
• Updates – US & EU policy challenges for market access: Stepping ahead
• Key elements - For successful drug pricing and future guidelines
• Impact of IRA on strategic pricing and contracting
• Integrating real-world data into pricing
• U.S. Inflation Reduction Act, and its implications
• Successful pricing strategy to widen your market access
• The new normal: HTA & Reimbursement challenges
• HTA and decision making in the reimbursement of medicines
• Staying ahead in the race - Update on pricing and market access in USA, EU & RoW
• Improve patient access - Accelerating patient access to innovative interventions
• Are you listening to your patients? Role of patient voice in market access
• The rise of digital health and value-based healthcare. Impact of AI ML
• Payer’s perspective – What are they looking for?
• The international pricing system – What drives parallel trade?
• Working & staying Connected for better health – Stakeholders / Industry / Payers / Physicians / Patients
• From PI to Payer to Patient: RWE From the Perspective of Each Key Stakeholder
• Optimizing market access and commercialization of new drugs through Real-World Evidence
• Recent regulatory updates & development – Making the best of the situation
• Implications for companies – What to Prepare for future?
• Be a part of the networking gathering

WHO SHOULD ATTEND?

• Senior decisions-makers from leading global pharmas, e.g., Senior Director, Executive Director, Senior Vice Presidents and Vice Presidents
• Senior decisions-makers from mid-size biotech and from mid-size pharmas, e.g., Senior Director, Executive Director, Vice Presidents, and Senior Vice Presidents
• Content experts from pharma/ life science agencies, consultancies, vendors, with focus on Pricing, Reimbursement, and Market Access
• Healthcare/ Pharma Payer and Policy decision-makers
• Industry journalists and industry experts looking for trends and new insights, and to establish new industry contacts

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Event Venue

Live! Casino & Hotel Philadelphia, 900 Packer Avenue, Philadelphia, United States